News

Nick Lench Portrait Photograph

Professor Nick Lench has been appointed as the Executive Director at the Nucleic Acid Therapy Accelerator (NATA), an MRC funded research initiative based on the Harwell Research Campus with a mission to accelerate the development of nucleic acid therapeutics, building partnerships with industry and academia from around the world. 
 
In his role as Executive Director, Nick will be responsible for defining the NATA’s scientific programmes, driving forward the NATA research agenda and will connect existing capabilities within the UK research landscape and work nationally and internationally, to engage emerging and established research leaders from all sectors and identify new funding opportunities.
 
Nick says: “I am delighted and excited to join NATA as Executive Director. NATA is uniquely placed to establish novel expertise and build partnerships to advance the development of nucleic acid therapeutics for the treatment of both rare and common diseases. Our mission is to provide access to expertise and infrastructure that will establish NATA and the UK as an international centre of excellence for nucleic acid based therapies.”
 
Professor John Iredale, MRC Interim Executive Chair says: “Professor Nick Lench has a wealth of economic, industry and entrepreneurial expertise. He will be an outstanding leader overseeing, shaping and delivering NATA’s scientific programmes and delivering on the promise of the investment.”